FDA Import Refusal AEK-8639074-4/21/1 — Actavis Laboratories FL Inc.
The FDA refused shipment AEK-8639074-4/21/1 from Actavis Laboratories FL Inc. (United States) on Jan 19, 2021. The refused product falls under Drugs and Biologics — NAPROXEN (ANTI-INFLAMMATORY). Cited charge: 75
Refusal Details
- Date
- Jan 19, 2021
- Country
- United States
- Product Category
- Drugs and Biologics
- Product Code
- 62GCA49 NAPROXEN (ANTI-INFLAMMATORY)
- Charges
- 75